Sequelae of foodborne Illness caused by 5 pathogens, Australia, Circa 2010

Emerging Infectious Diseases

Volumn 20, Issue 11, 2014, Pages 1865-1871

  Ford, Laura ^a   Kirk, Martyn ^a   Glass, Kathryn ^a   Hall, Gillian ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ARTICLE; AUSTRALIA; CAMPYLOBACTER; ESCHERICHIA COLI; FOOD CONTAMINATION; FOOD POISONING; FOOD SAFETY; GASTROENTERITIS; GASTROINTESTINAL INFECTION; GUILLAIN BARRE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MEDICAL RECORD; MONTE CARLO METHOD; MORTALITY; NONHUMAN; PATHOGENESIS; REACTIVE ARTHRITIS; SALMONELLA ENTERICA; SALMONELLOSIS; SHIGELLA; YERSINIA ENTEROCOLITICA; FOODBORNE DISEASES; HISTORY;

AUSTRALIA; FOODBORNE DISEASES; HISTORY, 21ST CENTURY; HOSPITALIZATION; HUMANS; INCIDENCE; MORTALITY;

EID: 84908100888     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2011.131316     Document Type: Article

References (29)

1. Kirk M, Ford L, Glass K, Hall G. Foodborne illness, Australia, circa 2000 and circa 2010. Emerg Infect Dis. 2014;20:1852–9
2. Abelson P, Potter Forbes M, Hall G. The annual cost of foodborne illness in Australia. Canberra (Australia): Commonwealth Department of Health and Ageing; 2006
3. Hughes RA, Rees JH. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis. 1997;176(Suppl2):92–8. http://dx.doi.org/10.1086/513793
4. Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr. 2010;28:545–52
5. Elliott EJ, Robins-Browne RM. Hemolytic uremic syndrome. Curr Probl Pediatr Adolesc Health Care. 2005;35:310–30. http:// dx.doi.org/10.1016/j.cppeds.2005.06.002
6. López EL, Contrini MM, Glastein E, Ayala SG, Santoro R, Ezcurra G, et al. An epidemiologic surveillance of Shiga-like toxinproducing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J. 2012;31:20–4. http://dx.doi.org/10.1097/INF.0b013e31822ea6cf
7. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–44. http://dx.doi.org/10.1111/j.1365-2036.2007.03399.x
8. Dai N, Cong Y, Yuan H. Prevalence of irritable bowel syndrome among undergraduates in southeast China. Dig Liver Dis. 2008;40:418–24. http://dx.doi.org/10.1016/j.dld.2008.01.019
9. Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: A review. J Adolesc Health. 2009;44:309–15. http://dx.doi.org/10.1016/ j.jadohealth.2008.12.007
10. Parkin R, Davies-Cole J, Balbus J. A definition for chronic sequelae applied to campylobacter and Guillian-Barré syndrome (GBS). Ann Epidemiol. 2000;10:473. http://dx.doi.org/10.1016/S1047- 2797(00)00108-3
11. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States major pathogens. Emerg Infect Dis. 2011;17:7–15. http://dx.doi. org/10.3201/eid1701.P11101
12. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011;25:347–57. http://dx.doi.org/10.1016/j.berh.2011.01.018
13. Alvarado AS, Brodsky SV, Nadasdy T, Singh N. Hemolytic uremic syndrome associated with Clostridium difficile infection. Clin Nephrol. 2014;81:302–6. http://dx.doi.org/10.5414/CN107691
14. D’Anchino M, Orlando D, De Feudis L. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect. 2002;45:169–72. http://dx.doi.org/10.1016/ S0163-4453(02)91038-8
15. Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 2007;5:457–60. http://dx.doi.org/10.1016/j.cgh.2006. 11.025
16. Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O’Brien SJ. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: A general practice research database study. J Infect Dis. 2006;194:95–7. http://dx.doi. org/10.1086/504294
17. McCarthy N, Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001;153:610–4. http://dx.doi.org/10.1093/aje/153.6.610
18. Allos BM. Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis. 1997;176(Suppl 2):S125–8. http://dx.doi.org/10.1086/513783
19. Vally H, Hall G, Dyda A, Raupach J, Knope K, Combs B, et al. Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000–2010. BMC Public Health. 2012;12:63–71. http://dx.doi. org/10.1186/1471-2458-12-63
20. Haagsma JA, Siersema PD, De Wit NJ, Havelaar AH. Disease burden of post-infectious irritable bowel syndrome in the Netherlands. Epidemiol Infect. 2010;138:1650–6. http://dx.doi.org/10.1017/ S0950268810000531
21. Government of Australia. National Notifiable Disease Surveillance System (NNDSS). [Cited 2013 Apr 5]. http://www9.health.gov.au/ cda/source/cda-index.cfm
22. Hall G, Kirk M. Foodborne illnesses in Australia: annual incidence circa 2000. Canberra (Australia): Commonwealth Department of Health and Ageing; 2005 April. report no 0642825769
23. Walker CL, Applegate JA, Black RE. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease. J Health Popul Nutr. 2012;30:257–61. http://dx.doi.org/10.3329/jhpn.v30i3.12288
24. Schwille-Kiuntke J, Frick JS, Zanger P, Enck P. Post-infectious irritable bowel syndrome—a review of the literature. Z Gastroenterol. 2011;49:997–1003. http://dx.doi.org/10.1055/s-0031-1281581
25. Vally H, Hall G, Scallan E, Kirk M., Angulo FJ. Higher rate of culture-confirmed Campylobacter infections in Australia than in the USA: is this due to differences in healthcare-seeking behaviour or stool culture frequency? Epidemiol Infect. 2009;137:1751–8. http://dx.doi.org/10.1017/S0950268809990161
26. Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM, Verhoef LP, Vijgen SM, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol. 2012;156:231–8. http://dx.doi.org/10.1016/j.ijfoodmicro.2012.03.029
27. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, et al. Longitudinal study of infectious intestinal disease in the UK (IID2study): incidence in the community and presenting to general practice. Gut. 2012;61:69–77. http://dx.doi.org/10.1136/gut.2011.238386
28. Sears A, Baker MG, Wilson N, Marshall J, Muellner P, Campbell DM, et al. Marked campylobacteriosis decline after interventions aimed at poultry, New Zealand. Emerg Infect Dis. 2011;17:1007–15. http://dx.doi.org/10.3201/eid/1706.101272
29. Baker MG, Kvalsvig A, Zhang J, Lake R, Sears A, Wilson N. Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988–2010. Emerg Infect Dis. 2012;18:226–33. http://dx.doi.org/10.3201/eid1802.111126